Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models.
Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models.
复制标题
DOI:
10.1158/1078-0432.ccr-07-5210
复制
发表时间:
2008-07-15
期刊:
影响因子:
--
通讯作者:
Raschellà G
中科院分区:
文献类型:
--
作者:
Vitali R;Mancini C;Cesi V;Tanno B;Mancuso M;Bossi G;Zhang Y;Martinez RV;Calabretta B;Dominici C;Raschellà G
We assessed the relevance of Slug (SNAI2) for apoptosis resistance and invasion potential of neuroblastoma (NB) cells in vitro and in vivo. We evaluated the effect of Imatinib Mesylate (IM) on invasion and analyzed the genes modulated by IM treatment in NB cells. Slug expression, inhibited by IM treatment, was knocked-down in NB cells by RNA interference and the effects on invasion and apoptosis were evaluated in vitro. A pseudometastatic model of NB in SCID mice was used to assess the effects of Slug-silencing alone or in combination with IM treatment on metastasis development. Microarray analysis revealed that several genes, including Slug, were down-regulated by IM. Slug expression was detectable in 8 of 10 human NB cell lines. Two Slug-expressing cell lines were infected with a vector encoding a miRNA to Slug mRNA. Infected cells with reduced levels of Slug were tested for the expression of apoptosis-related genes (p53, Bax, Bcl-2), previously identified as Slug targets. Bcl-2 was down-regulated in Slug-interfered cells. Slug down-regulation increased sensitivity to apoptosis induced by IM, etoposide or doxorubicin. Invasion of Slug-silenced cells was reduced in vitro. Animals injected with Slug-silenced cells had fewer tumors than controls and the inhibition of tumor growth was even higher in animals treated with IM. Slug down-regulation facilitates apoptosis induced by pro-apoptotic drugs in NB cells and decreases their invasion capability in vitro and in vivo. Slug inhibition, possibly combined with IM, may represent a novel strategy for treatment of metastatic NB.